NASDAQ · Biotechnology

Lunai Bioworks Inc. (LNAI) Stock

$2.29 -1.93% NASDAQ: LNAI Healthcare

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems.

Valuation

MetricValue
Price$2.29
Market Cap$10.36M
P/E Ratio-0.04
P/B Ratio-0.76
P/S Ratio504.44
EPS (TTM)$-10.78
52-Week High$28.00
52-Week Low$1.21
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE892.52%
ROA-2225.00%
ROCE104.45%
Gross Margin-3.61%
Operating Margin-469.92%
Net Margin0.00%
Debt/Equity-0.15
Current Ratio0.03

Annual Financials (USD)

Metric20202021202220232024
Revenue$0$0$0$0$0
Operating Profit$-23.0M$-116.0M$-39.0M$-82.0M$-19.0M
Net Profit$-27.0M$-113.0M$-40.0M$-88.0M$-178.0M
EPS$-45.36$-172.80$-56.80$-72.80$-86.24
Op Margin—————

Balance Sheet (USD)

Metric20202021202220232024
Total Assets$190.0M$85.0M$58.0M$163.0M$8.0M
Total Liabilities$15.0M$12.0M$12.0M$31.0M$30.0M
Cash$21.0M$9.0M$2.0M$0$0
Borrowings$7.0M$7.0M$6.0M$4.0M$10.0M

Latest News

LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS PR Newswire · Jun 17, 2026 Top Premarket Gainers MT Newswires · Jun 17, 2026 Why Did LNAI Stock Soar Over 100% In Pre-Market Trading Today? Stocktwits · Jun 17, 2026 Lunai Bioworks and BrainStorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration PR Newswire · May 28, 2026 LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT PR Newswire · May 20, 2026

Cash Flow (USD)

Metric20202021202220232024
Operating Cash Flow$-21.0M$-16.0M$-12.0M$-11.0M$-8.0M
Investing Cash Flow$0$0$0$-1.0M$-1.0M
Financing Cash Flow$1.0M$0$1.0M$-1.0M$-1.0M
Net Cash Flow$12.0M$-11.0M$-7.0M$-2.0M$0
Free Cash Flow$-21.0M$-16.0M$-12.0M$-11.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.07
FCF Yield-47.54%
Quick Ratio0.19
Interest Coverage-16.23
Return 1Y-86.74%
Return 3Y-93.49%
Return 5Y-99.18%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAPAdaptimmune Therapeutics plc $0.05 -3.00% -0.16 $75.16M 0.00%
ANLAdlai Nortye Ltd. $13.26 +2.00% -8.19 $703.84M 0.00%
APLMApollomics, Inc. $18.76 +2.99% -2.41 $20.69M 0.00%
BLRXBioLineRx Ltd. $2.85 -2.45% -1.36 $12.39M 0.00%
ERNA $3.35 -3.46% 0.01 $1.05M 0.00%

About Lunai Bioworks Inc.

Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."

Lunai Bioworks Inc. is led by CEO David H. Weinstein, employs 29 people, headquartered in US, publicly traded since 2025.

Lunai Bioworks Inc. (LNAI) stock trades at $2.29 with a market capitalization of $10.36M. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of -0.76, price-to-sales of 504.44. Over the past 52 weeks the stock has ranged between $1.21 and $28.00, and currently trades 91.8% below its 52-week high.

On profitability, Lunai Bioworks Inc. generates a return on equity (ROE) of 892.52% — well above the market average, a sign of a high-quality business, return on capital employed of 104.45%, an operating margin of -469.92%, a net profit margin of 0.00%.

Official website: www.lunaibioworks.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides